177 related articles for article (PubMed ID: 17764874)
1. The role of tissue factor in patients undergoing open repair of ruptured and nonruptured abdominal aortic aneurysms.
Hobbs SD; Haggart P; Fegan C; Bradbury AW; Adam DJ
J Vasc Surg; 2007 Oct; 46(4):682-6. PubMed ID: 17764874
[TBL] [Abstract][Full Text] [Related]
2. Myocardial injury and systemic fibrinolysis in patients undergoing repair of ruptured abdominal aortic aneurysm: a preliminary report.
Haggart PC; Adam DJ; Ludman PF; Ludman CA; Bradbury AW
Eur J Vasc Endovasc Surg; 2001 Jun; 21(6):529-34. PubMed ID: 11397027
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of soluble tumor necrosis factor receptors are associated with increased mortality rates in patients who undergo operation for ruptured abdominal aortic aneurysm.
Adam DJ; Lee AJ; Ruckley CV; Bradbury AW; Ross JA
J Vasc Surg; 2000 Mar; 31(3):514-9. PubMed ID: 10709065
[TBL] [Abstract][Full Text] [Related]
4. Hemostatic markers before operation in patients with acutely symptomatic nonruptured and ruptured infrarenal abdominal aortic aneurysm.
Adam DJ; Haggart PC; Ludlam CA; Bradbury AW
J Vasc Surg; 2002 Apr; 35(4):661-5. PubMed ID: 11932659
[TBL] [Abstract][Full Text] [Related]
5. Changes in thrombin generation, fibrinolysis, platelet and endothelial cell activity, and inflammation following endovascular abdominal aortic aneurysm repair.
Abdelhamid MF; Davies RS; Adam DJ; Vohra RK; Bradbury AW
J Vasc Surg; 2012 Jan; 55(1):41-6. PubMed ID: 21975058
[TBL] [Abstract][Full Text] [Related]
6. Coagulation and fibrinolysis in patients undergoing operation for ruptured and nonruptured infrarenal abdominal aortic aneurysms.
Adam DJ; Ludlam CA; Ruckley CV; Bradbury AW
J Vasc Surg; 1999 Oct; 30(4):641-50. PubMed ID: 10514203
[TBL] [Abstract][Full Text] [Related]
7. Fibrinolysis in patients with an abdominal aortic aneurysm with special emphasis on rupture and shock.
Skagius E; Siegbahn A; Bergqvist D; Henriksson AE
J Thromb Haemost; 2008 Jan; 6(1):147-50. PubMed ID: 17922806
[TBL] [Abstract][Full Text] [Related]
8. More patients are treated for nonruptured abdominal aortic aneurysms, but the proportion of women remains unchanged.
Larsson E; Granath F; Swedenborg J; Hultgren R
J Vasc Surg; 2008 Oct; 48(4):802-7. PubMed ID: 18639419
[TBL] [Abstract][Full Text] [Related]
9. Selected clotting factors in blood of patients with abdominal aortic aneurysms.
Kotschy M; Witkiewicz W; Grendziak R; Dubis J; Zapotoczny N; Kotschy D
Kardiol Pol; 2012; 70(6):574-9. PubMed ID: 22718374
[TBL] [Abstract][Full Text] [Related]
10. Elevated tissue plasminogen activator in patients with screening-detected abdominal aortic aneurysm.
Wanhainen A; Nilsson TK; Bergqvist D; Boman K; Björck M
J Vasc Surg; 2007 Jun; 45(6):1109-13. PubMed ID: 17543671
[TBL] [Abstract][Full Text] [Related]
11. To what extent has endovascular aneurysm repair influenced abdominal aortic aneurysm management in the state of Illinois?
Leon LR; Labropoulos N; Laredo J; Rodríguez HE; Kalman PG
J Vasc Surg; 2005 Apr; 41(4):568-74. PubMed ID: 15874918
[TBL] [Abstract][Full Text] [Related]
12. Vascular surgical society of great britain and ireland: inhibition of systemic fibrinolysis is associated with myocardial injury in patients operated on for ruptured abdominal aortic aneurysm.
Adam DJ; Evans SM; Ludlam CA; Bradbury AW
Br J Surg; 1999 May; 86(5):695. PubMed ID: 10361322
[TBL] [Abstract][Full Text] [Related]
13. Activity of thrombin-activatable fibrinolysis inhibitor in the plasma of patients with abdominal aortic aneurysm.
Dubis J; Zuk N; Grendziak R; Zapotoczny N; Pfanhauser M; Witkiewicz W
Blood Coagul Fibrinolysis; 2014 Apr; 25(3):226-31. PubMed ID: 24378973
[TBL] [Abstract][Full Text] [Related]
14. The systemic inflammatory response syndrome, organ failure, and mortality after abdominal aortic aneurysm repair.
Bown MJ; Nicholson ML; Bell PR; Sayers RD
J Vasc Surg; 2003 Mar; 37(3):600-6. PubMed ID: 12618699
[TBL] [Abstract][Full Text] [Related]
15. Early coagulopathy in patients with ruptured abdominal aortic aneurysm.
Fransson M; Rydningen H; Henriksson AE
Clin Appl Thromb Hemost; 2012; 18(1):96-9. PubMed ID: 21733939
[TBL] [Abstract][Full Text] [Related]
16. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
Falciani M; Gori AM; Fedi S; Chiarugi L; Simonetti I; Dabizzi RP; Prisco D; Pepe G; Abbate R; Gensini GF; Neri Serneri GG
Thromb Haemost; 1998 Mar; 79(3):495-9. PubMed ID: 9531029
[TBL] [Abstract][Full Text] [Related]
17. A decade of change in abdominal aortic aneurysm repair in the United States: Have we improved outcomes equally between men and women?
Dillavou ED; Muluk SC; Makaroun MS
J Vasc Surg; 2006 Feb; 43(2):230-8; discussion 238. PubMed ID: 16476592
[TBL] [Abstract][Full Text] [Related]
18. Thrombin-activatable fibrinolysis inhibitor (TAFI) antigen and activity assay in patients with primary hypothyroidism.
Ermantas N; Guldiken S; Demir M; Tugrul A
Clin Appl Thromb Hemost; 2010 Oct; 16(5):568-73. PubMed ID: 19959491
[TBL] [Abstract][Full Text] [Related]
19. Increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels in patients with primary hyperparathyroidism.
Erem C; Kocak M; Nuhoglu I; Yilmaz M; Ucuncu O
Eur J Endocrinol; 2009 May; 160(5):863-8. PubMed ID: 19233920
[TBL] [Abstract][Full Text] [Related]
20. Malondialdehyde as an indicator of oxidative stress during abdominal aortic aneurysm repair.
Papalambros E; Sigala F; Georgopoulos S; Paraskevas KI; Andreadou I; Menenakos X; Sigalas P; Papalambros AL; Vourliotakis G; Giannopoulos A; Bakoyiannis C; Bastounis E
Angiology; 2007; 58(4):477-82. PubMed ID: 17875961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
